SEOUL, Südkorea, 18. Februar 2025 /PRNewswire/ — Am 17. Februar gab VIVOZON Pharmaceutical bekannt, dass sein nicht-opioides Analgetikum UNAFRA Inj. am 12. Dezember 2024 zugelassen wurde. (Aktiver Wirkstoff: Opiranserin HCl) hat vom Ministerium für Lebensmittel- und…
Tag: PR Newswire
Deutschland, 18. Februar 2025 /PRNewswire/ — HOOKII präsentiert den weltweit ersten Rasenmäherroboter mit 3D LiDAR & Vision Fusion, speziell entwickelt für die kleineren, komplexeren Gärten in Europa. Mit 2x schnellerem Mähen und über 95 % Abdeckung passt sich HOOKII mühelos an…
Schnellere Vermarktung der Depolymerisationstechnologie durch umfassendes Recycling-Lösungszentrum, das in die bestehende Produktionsinfrastruktur integriert ist Validierung der Umwandlung von Abfallressourcen in Material und Aufbau eines vollständigen Ressourcenkreislaufsystems mit…
SEÚL, Corea del sur, 18 de febrero de 2025 /PRNewswire/ — El 17 de febrero, VIVOZON Pharmaceutical anunció que su analgésico no opioide, UNAFRA Inj., fue aprobado el 12 de diciembre de 2024. (Ingrediente activo: Opiranserin HCl) recibió la aprobación del Ministerio de Seguridad de…
AALST and MECHELEN, Bélgica, 18 de febrero de 2025 /PRNewswire/ — Bluecrux, una empresa líder en consultoría y tecnología de la cadena de valor, ha sido reconocida como pionera en múltiples informes de Gartner®. Este reconocimiento destaca el enfoque innovador de la compañía para…
PISCATAWAY, N.J., Feb. 18, 2025 /PRNewswire/ — GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emission reduction targets. These targets have been verified by the Science Based Targets…
Semiconductor leader brings more than two decades of executive leadership expertise with a primary focus in Global Operations, Manufacturing and Supply Chain. KISTA, Sweden, Feb. 18, 2025 /PRNewswire/ — Sivers Semiconductors AB (STO: SIVE), a global leader in photonics and wireless…
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai…
BEIJING, Feb. 18, 2025 /PRNewswire/ — A news report from sinolub: In the era of rapid digitalization and intelligent development, China’s technology is rising on the global stage at an unprecedented speed. From artificial intelligence to high-performance computing, and from basic…
STOCKHOLM, Feb. 18, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai…